FDA Approval on $CEMI - $CEMI Chembio Diagnostics Got a FDA Emergency Use Nod For Its COVID-19 Antibody Test
The FDA has granted emergency use authorization to Chembio Diagnostics Inc's (NASDAQ: CEMI) COVID-19 antibody test.
The nod comes for LumiraDx SARS-CoV-2 Ab Test, a microfluidic immunofluorescence assay for the qualitative detection of total antibodies in whole human blood, plasma, or serum for indication of recent or prior infection.
Recently, the Company received a $28 million order to supply DPP SARS-CoV-2 Antigen tests for delivery during 2021 in Brazil.
Nothing I say, post, or do should ever be considered financial advice. I may be holding a long, short or no position. I am NOT or NEVER have I been compensated to post on here or anywhere and all my posts are for entertainment purposes only.